Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05774951
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2023-02-16
Brief Title:
A Study of Camizestrant in ERHER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Sponsor:
AstraZeneca
Organization:
AstraZeneca